Table 1.

Characteristics of Antiretroviral Therapy–Experienced, HIV-Infected Adults at Study Entry During 2000–2013

Variable	HTN (n = 9547)		No HTN (n = 58858)		DM (n = 5881)		No DM (n = 80908)		CKD (n = 1785)		No CKD (n = 50626)
	PY = 41291		PY = 323788		PY = 23918		PY = 452258		PY = 10053		PY = 288382
Age, y
<40	2734	29	27002	46	1488	25	33831	42	430	24	24012	47
40–49	4201	44	21555	37	2530	43	30270	37	782	44	18553	37
50–59	2234	23	8673	15	1601	27	13789	17	480	27	7044	14
60–69	378	4	1628	3	262	4	3018	4	93	5	1017	2
Sex
Male	8464	89	48908	83	4842	82	67621	84	1481	83	42200	83
Race
Non-black	4836	51	35330	60	2893	49	47838	59	884	50	28592	56
Black	4711	49	23528	40	2988	51	33070	41	901	50	22034	44
Injection drug use as HIV transmission risk
No	6829	72	47617	81	4230	72	63921	79	1191	67	39948	79
Smokinga
Never	717	8	5927	10	397	7	9153	11	146	8	5653	11
Ever	2615	27	20798	35	1565	27	30142	37	646	36	19692	39
Missing	6215	65	32133	55	3919	67	41613	51	993	56	25281	50
BMI, kg/m2
<18.5	913	10	10268	17	429	7	14001	17	28	2	727	1
18.5–24.9	685	7	5961	10	408	7	8688	11	284	16	9293	18
25–29.9	334	3	2184	4	353	6	3401	4	150	8	5655	11
30–40	58	1	304	1	73	1	473	1	55	3	2391	5
>40	57	1	851	1	35	1	1102	1	12	1	401	1
Missing	7500	79	39290	67	4583	78	53243	66	1256	70	32159	64
AIDS
No	7811	82	47252	80	4668	79	65016	80	1341	75	40770	81
Calendar period of ART initiation
1996–1999	4651	49	17707	30	2804	48	25534	32	851	48	14895	29
2000–2005	3669	38	21231	36	2361	40	29892	37	766	43	19204	38
2006–2013	1101	12	17595	30	638	11	22624	28	138	8	14962	30
CD4 count, cells/µL
>500	1684	18	10208	17	1257	21	14474	18	284	16	9345	18
350–499	1219	13	8223	14	852	14	11790	15	197	11	7701	15
200–349	1772	19	11964	20	1021	17	17167	21	351	20	11118	22
<200	4870	51	28458	48	2751	47	37471	46	953	53	22459	44
ART and HIV RNA, copies/mL
≤400, on ART	2848	30	16091	27	1933	33	23031	28	439	25	14279	28
>400, on ART	3620	38	26026	44	2202	37	35650	44	853	48	24334	48
Off ART	207	2	1235	2	187	3	1936	2	60	3	1120	2
Missing	2872	30	15506	26	1559	27	20291	25	433	24	10893	22

Data are presented as No. (%) unless otherwise indicated. Statistical differences were assessed comparing cases to noncases for each NCD. All covariates were statistically significant (P < .05) with the exception of sex and BMI for the CKD analysis.

Abbreviations: ART, antiretroviral therapy; BMI, body mass index; CKD, chronic kidney disease; DM, diabetes mellitus; HIV, human immunodeficiency virus; HTN, hypertension; NCD, noncommunicable diseases; PY, person-years.

^aSmoking data in NA-ACCORD included observed and imputed observations. Across all 3 study populations, 3% of participants were imputed to be never smokers, 10% were imputed to be ever smokers, 7%–8% were observed as never smokers, 24%–29% were observed as ever smokers, and 50%–56% had missing smoking data. Results of our analyses pooled smoking coefficients across 5 datasets with imputed smoking status, and we obtained valid inferences by accounting for associated covariance matrices between imputed datasets.